Skip to Content
Merck
CN
  • Ketoprofen is more effective than diclofenac after oral surgery when used as a preemptive analgesic: a pilot study.

Ketoprofen is more effective than diclofenac after oral surgery when used as a preemptive analgesic: a pilot study.

Journal of oral & facial pain and headache (2014-05-14)
Grace Carolaine Esquivel Velásquez, Luis A German Santa Cruz, Mario Alberto Isiordia Espinoza
ABSTRACT

To evaluate the preemptive analgesia of ketoprofen in comparison with diclofenac after mandibular third molar surgery. This study was a double-blind, randomized clinical trial. Forty patients were randomized into two treatment groups (each with 20 patients) by using a series of random numbers: group A received ketoprofen 100 mg and group B received diclofenac 75 mg, all intramuscularly. Surgery was done 30 minutes after analgesic treatments. The durations of analgesia, pain intensity, analgesic consumption, and side effects were evaluated. The statistical analysis was done using the chi-square, Student t, Mann-Whitney U, and Log-Rank tests. The duration of analgesia was longer in the ketoprofen group when compared with the diclofenac group. The number of patients taking the first rescue analgesic at 6 hours was lower in the ketoprofen group in comparison with the diclofenac group. Patients who received ketoprofen had lower pain intensity compared with patients who received diclofenac. Intramuscular ketoprofen 100 mg is more effective than intramuscular diclofenac 75 mg after mandibular third molar extraction when used as a preemptive analgesic.

MATERIALS
Product Number
Brand
Product Description

Diclofenac potassium, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Diclofenac sodium salt
Supelco
Diclofenac sodium salt, analytical standard
Sigma-Aldrich
Clonixin, ≥98% (HPLC)
Supelco
Diclofenac sodium salt, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
L-Lysine, analytical standard
Sigma-Aldrich
L-Lysine, ≥98% (TLC)
Sigma-Aldrich
L-Lysine acetate salt, ≥98% (HPLC)
Sigma-Aldrich
L-Lysine, crystallized, ≥98.0% (NT)
Sigma-Aldrich
L-Lysine, Vetec, reagent grade, ≥98%
Diclofenac for system suitability, European Pharmacopoeia (EP) Reference Standard
Lysine hydrochloride, European Pharmacopoeia (EP) Reference Standard
Lysine acetate, European Pharmacopoeia (EP) Reference Standard
Supelco
Ketoprofen, Pharmaceutical Secondary Standard; Certified Reference Material
Diclofenac sodium, European Pharmacopoeia (EP) Reference Standard
USP
Ketoprofen, United States Pharmacopeia (USP) Reference Standard
Supelco
L-Lysine Acetate, Pharmaceutical Secondary Standard; Certified Reference Material
USP
Diclofenac sodium, United States Pharmacopeia (USP) Reference Standard
Ketoprofen, European Pharmacopoeia (EP) Reference Standard
Supelco
Ketoprofen, VETRANAL®, analytical standard
Sigma-Aldrich
Ketoprofen, meets USP testing specifications
Sigma-Aldrich
L-Lysine monohydrochloride, from non-animal source, meets EP, JP, USP testing specifications, suitable for cell culture, 98.5-101.0%
Sigma-Aldrich
L-Lysine monohydrochloride, BioUltra, ≥99.5% (AT)
Supelco
L-Lysine monohydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
L-Lysine monohydrochloride, reagent grade, ≥98% (HPLC)
Sigma-Aldrich
Ketoprofen, ≥98% (TLC)
Supelco
L-Lysine monohydrochloride, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland